BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

I Peace and Vita Therapeutics Partner to Develop Universal Hypoimmune iPSC Lines for Cell Therapy

Leading GMP cell CDMO I Peace, Inc. specializing in induced pluripotent stem cells (iPSCs) and iPSC-derived cell therapies, announced that the co...

July 11, 2025 | News

Univercells Technologies and Repligen Collaborate to Advance Real-Time Monitoring in Viral Vector and Vaccine Manufacturing

Univercells Technologies, a Donaldson Life Sciences business and global provider of bioprocessing solutions, announced a collaboration with Repli...

July 10, 2025 | News

SCG Cell Therapy Secures China NMPA IND Approval for First Cell Therapy Targeting Chronic Hepatitis B

SCG Cell Therapy Pte Ltd (SCG), a clinical-stage biotechnology company pioneering TCR T cell therapy for infectious diseases and associated cancers, announ...

July 08, 2025 | News

Japanese Life Sciences Delegation Strengthens Collaboration with North Carolina’s Innovation Ecosystem

A high-level Japanese delegation specializing in life sciences concluded a three-day visit to North Carolina (June 24–26), further strengthening ties...

July 07, 2025 | News

AvenCell Secures Up to $40 Million AMED Grant to Advance Dual-Antigen Allogeneic CAR-T Therapy

AvenCell Japan, a wholly owned subsidiary of AvenCell Therapeutics, a private, clinical-stage biotechnology company developing best-in-class CAR-T therapie...

July 02, 2025 | News

HanchorBio Licenses Novel CD47 Fusion Protein HCB101 to Henlius in $200 Million+ Regional Deal

HanchorBio Inc. (7827.TWO), a global clinical-stage biotechnology company developing innovative immunotherapies for oncology and autoimmune diseases, annou...

July 02, 2025 | News

Klotho Neurosciences Advances KLTO-202 Gene Therapy Manufacturing for ALS Clinical Trials

Klotho Neurosciences, Inc. announced that it is moving forward with manufacturing and process development work in preparation for clinical trials of K...

July 01, 2025 | News

Porton Advanced and EVA Pharma Partner to Boost CAR T-Cell Therapy Manufacturing in the Middle East and Africa

Porton Advanced Solutions, a global leading cell and gene therapy CDMO service provider, and EVA Pharma, one of the leading pharmaceutical companies d...

June 27, 2025 | News

Invetech and AiCella Forge Strategic Alliance to Advance AI-Driven Cell Therapy Manufacturing

Invetech, a global leader in solving complex manufacturing and product development challenges in the advanced therapies and diagnostics markets, today anno...

June 27, 2025 | News

AGC Biologics Launches Cell Therapy Manufacturing Services in Yokohama to Expand Global CDMO Footprint

AGC Biologics, your friendly CDMO expert, will commence cell therapy process development and clinical manufacturing services on July 1, 2025, at AGC Inc....

June 26, 2025 | News

Xcell Biosciences and Thermo Fisher Scientific Unite to Advance Treg and TIL Cell Therapies for Autoimmune and Solid Tumor Diseases

Xcell Biosciences (Xcellbio), a San Francisco-based instrumentation company focused on cell and gene therapy applications, today announced a strategic coll...

June 25, 2025 | News

Terumo BCT Showcases 3-in-1 CAR-T Manufacturing Protocol in Cytotherapy

Protocol published in Cytotherapy1 shows activation and viral transduction can be performed on Terumo BCT’s Quantum Cell Expansion System.&nbs...

June 19, 2025 | News

HELP Therapeutics and China Resources Sanjiu Forge Strategic Partnership to Advance Groundbreaking iPSC-Derived Therapy for Heart Failure in China

HELP Therapeutics, a global leader in regenerative medicine, and China Resources Sanjiu Pharmaceutical Company, one of China's largest pharmaceut...

June 17, 2025 | News

Nuevocor Receives FDA IND Clearance to Advance NVC-001 Gene Therapy for LMNA-Related Dilated Cardiomyopathy

LMNA-related dilated cardiomyopathy (LMNA DCM) is one of the most aggressive forms of DCM, affecting approximately 100,000 individuals in the United...

June 11, 2025 | News

Stay Connected